Characterization of Metabolic Alterations in Mouse Models of Neurodevelopmental Disorders
Background: Prevalence of metabolic disturbances is higher among individuals with neurodevelopmental disorders (NDDs), yet this association has been poorly studied. Investigation into human disease remains challenging, as a complete pathophysiological understanding relies on accurate modeling and hi...
Main Author: | Menzies, Caitlin |
---|---|
Other Authors: | Lacoste, Baptiste |
Format: | Others |
Language: | en |
Published: |
Université d'Ottawa / University of Ottawa
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/42256 http://dx.doi.org/10.20381/ruor-26478 |
Similar Items
-
Structural and Lipidomic Alterations of Striatal Myelin in 16p11.2 Deletion Mouse Model of Autism Spectrum Disorder
by: Jun Ju, et al.
Published: (2021-08-01) -
Rare Pathogenic Copy Number Variation in the 16p11.2 (BP4–BP5) Region Associated with Neurodevelopmental and Neuropsychiatric Disorders: A Review of the Literature
by: Natália Oliva-Teles, et al.
Published: (2020-12-01) -
<i>FMR1</i> and Autism, an Intriguing Connection Revisited
by: William Fyke, et al.
Published: (2021-08-01) -
Role of Cerebrovascular Abnormalities in the 16p11.2 Deletion Autism Syndrome
by: Ouellette, Julie
Published: (2019) -
Rethinking Intellectual Disability from Neuro- to Astro-Pathology
by: Álvaro Fernández-Blanco, et al.
Published: (2020-11-01)